TITAN PHARMACEUTICALS INC — Director's Dealing 2018

Sep 26, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TITAN PHARMACEUTICALS INC (TTNP)
CIK: 0000910267
Period of Report: 2018-09-21

Reporting Person: Rubin Marc (Director, Executive Chairman)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-09-21	Common Stock	P	400000	$0.25	Acquired	556317	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-09-21	Warrants	$0.25	A	400000	Acquired	2023-09-25	common stock (400000)	Direct